Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
6(32%)
Results Posted
17%(1 trials)

Phase Distribution

Ph not_applicable
7
37%
Ph phase_2
5
26%
Ph phase_3
3
16%
Ph phase_1
4
21%

Phase Distribution

4

Early Stage

5

Mid Stage

3

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
4(21.1%)
Phase 2Efficacy & side effects
5(26.3%)
Phase 3Large-scale testing
3(15.8%)
N/ANon-phased studies
7(36.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

6

trials recruiting

Total Trials

19

all time

Status Distribution
Active(7)
Completed(6)
Other(6)

Detailed Status

unknown6
Completed6
Recruiting4
Active, not recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
6
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (21.1%)
Phase 25 (26.3%)
Phase 33 (15.8%)
N/A7 (36.8%)

Trials by Status

recruiting421%
unknown632%
completed632%
active_not_recruiting211%
not_yet_recruiting15%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT07450963Phase 2

Cadonilimab Combined With RT in LACC Patients Ineligible for CCRT

Not Yet Recruiting
NCT05331521Phase 3

A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).

Recruiting
NCT04250922Phase 2

LAM561 With RT and TMZ for Adults With Glioblastoma

Active Not Recruiting
NCT03576417Phase 3

A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck

Active Not Recruiting
NCT06214572Phase 2

Radiation Therapy in Unresectable Gall Bladder Cancer

Recruiting
NCT04261504Not Applicable

Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention

Completed
NCT06356935Not Applicable

Effects of Heavy-load Resistance Training

Completed
NCT04558879Not Applicable

Exercise and Sleep in Parkinson's Disease

Recruiting
NCT03411408Not Applicable

Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma.

Unknown
NCT05761054Not Applicable

Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT)

Recruiting
NCT03867123Phase 1

A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients

Completed
NCT05068453Phase 1

Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver Metastasis

Unknown
NCT02903069Phase 1

Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer

Completed
NCT03844763Phase 1

Targeting the Tumor Microenvironment in R/M SCCHN

Unknown
NCT03939845Phase 3

A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi

Unknown
NCT03138642Phase 2

Mucosal Melanoma of Head and Neck in Intensity-modulated Radiotherapy Era

Unknown
NCT02724618Phase 2

Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT)

Unknown
NCT01767480Not Applicable

Effects of Intensive Robot-assisted Therapy in Patients With Subacute Stroke

Completed
NCT01385475Not Applicable

Resistance Training to Improve Physical Function in the Elderly

Completed

All 19 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
19